| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.03 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.099 | 0.03 |